Catena Biosciences
Berkeley, CA
Catena Biosciences is a biotech startup based on research from the Francis and Doudna labs at UC Berkeley focusing on the treatment and cure of autoimmune disorders. Catena’s platform differentiates on the ability to fuse proteins together using enzyme activation of native amino acids to create new treatments in oncology, autoimmune disorders and vaccine development!
catenabiosciences.comCompany Details
Founded
- 2020
Employees
- Between 5 - 20 employees
Raised
- $8,050,000
Headquarters Location
- Berkeley, CA
Public
- No
Acquired
- No
CEO
- Marco Lobba
Founders
- Matthew FrancisGregorio (Geo) GuillenMarco Lobba
Company Collections
These are collections Catena Biosciences is a part of. Click on the collection name to view similar companies.